5 months ago
APLT
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Bottom 3%
#4750 out of 4861 analysts
Average Return
-5.31%
Win Rate
36%86 out of 240
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-10 - 2024-03-08 | Buy |
Ambrx Biopharma IncAMAM | +210.77% | $9.01 | $28.00 | 2023-11-14 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
a year ago
MNMD
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 17 | Buy | $137.00 | +35.14% | Upgrades | 7 days ago |
Biocryst Pharmaceuticals IncBCRX | 13 | Buy | $11.00 | +48.65% | Reiterates | 10 days ago |
Vertex Pharmaceuticals IncVRTX | 50 | Hold | $420.00 | -14.13% | Maintains | 20 days ago |
Aardvark Therapeutics IncAARD | 2 | Buy | $21.00 | +200.00% | Reiterates | 20 days ago |
Sarepta Therapeutics IncSRPT | 29 | Hold | $87.00 | +61.74% | Downgrades | 21 days ago |
Moonlake ImmunotherapeuticsMLTX | 1 | Buy | $67.00 | +74.82% | Initiates Coverage On | a month ago |
Gh Research PLCGHRS | 1 | Buy | $31.00 | +240.66% | Initiates Coverage On | a month ago |
Pliant Therapeutics IncPLRX | 13 | Hold | $3.00 | +105.48% | Maintains | 2 months ago |
Neumora Therapeutics IncNMRA | 6 | Hold | $4.00 | +518.24% | Reiterates | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 10 | Hold | $20.00 | +117.39% | Maintains | 2 months ago |
Karyopharm Therapeutics IncKPTI | 10 | Buy | $45.00 | +809.09% | Reiterates | 2 months ago |
Ptc Therapeutics IncPTCT | 14 | Buy | $63.00 | +32.94% | Maintains | 2 months ago |
Biogen IncBIIB | 32 | Buy | $225.00 | +89.70% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 29 | Hold | $90.00 | -13.91% | Maintains | 2 months ago |
Incyte CorpINCY | 19 | Hold | $68.00 | +16.82% | Maintains | 2 months ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | +36.89% | Maintains | 3 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | +144.80% | Reiterates | 3 months ago |
Intra Cellular Therapies IncITCI | 17 | Hold | $132.00 | +0.10% | Downgrades | 3 months ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | +22.95% | Downgrades | 3 months ago |
Contineum Therapeutics IncCTNM | 4 | Buy | $31.00 | +571.00% | Reiterates | 3 months ago |
Applied Therapeutics IncAPLT | 5 | Hold | $1.50 | +350.45% | Maintains | 4 months ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | +158.73% | Downgrades | 4 months ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | -46.16% | Upgrades | 5 months ago |
Regeneron Pharmaceuticals IncREGN | 30 | Buy | $1,215.00 | +115.75% | Maintains | 6 months ago |
Galapagos NvGLPG | 10 | Hold | $30.00 | +21.65% | Maintains | 6 months ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | +81.82% | Maintains | 6 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 6 | Buy | $82.00 | +1,259.87% | Reiterates | 7 months ago |
Xenon Pharmaceuticals IncXENE | 13 | Buy | $55.00 | +56.65% | Reiterates | 8 months ago |
89bio IncETNB | 13 | Hold | $12.00 | +98.02% | Maintains | 8 months ago |
Mind Medicine IncMNMD | 9 | Buy | $22.00 | +281.28% | Reiterates | a year ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | a year ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 2 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 2 years ago |
Atai Life Sciences NvATAI | 3 | Hold | $9.00 | N/A | Maintains | 3 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 3 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 4 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 5 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 7 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 8 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.